Government of Netherlands Report issue

Government Phase 1 Phase 2 Phase 3 Phase 4
Founded: Amsterdam Netherlands (1581)

Organization Overview

First Clinical Trial
2005
NCT00229099
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Center for Man in Aviation, Royal Netherlands Air Force | Dutch Ministry of Defense | National Institute for Public Health and Environment Netherlands | Netherlands: Ministry of Health, Welfare and Sports | Public Health Service Gelderland-Zuid | Public Health Service Haaglanden | Public Health Service of Amsterdam | Public Health Service Rotterdam-Rijnmond | R. van Mourik

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 3)

Atrial Fibrillation (Phase 3)

Atrophic Vaginitis (Phase 1)

Atrophy (Phase 1)

Attention Deficit Disorder with Hyperactivity (Phase 3)

Coronavirus Infections (Phase 3)

Fistula (Phase 4)

Gonorrhea (Phase 3)

Hemorrhoids (Phase 4)

Hernia (Phase 4)

Hernia, Inguinal (Phase 4)

Hyperkinesis (Phase 3)

Hypotension (Phase 1)

Kidney Diseases (Phase 2)

Kidney Failure, Chronic (Phase 3)

Marijuana Abuse (Phase 1)

Multiple Myeloma (Phase 3)

Pain, Postoperative (Phase 4)

Pneumococcal Infections (Phase 3)

Pneumonia (Phase 3)

Rectal Fistula (Phase 4)

Renal Insufficiency (Phase 2)

Renal Insufficiency, Chronic (Phase 2)

Schistosomiasis (Phase 3)

Schistosomiasis haematobia (Phase 3)

Schistosomiasis mansoni (Phase 3)

Severe Acute Respiratory Syndrome (Phase 3)

Tachycardia (Phase 1)

Vaginitis (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 21
  • # of Trial APIs: 33